83 FR 6177 - Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 83, Issue 30 (February 13, 2018)

Page Range		6177-6177
FR Document		2018-02829

Federal Register, Volume 83 Issue 30 (Tuesday, February 13, 2018)

[Federal Register Volume 83, Number 30 (Tuesday, February 13, 2018)]
[Notices]
[Page 6177]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2018-02829]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Management 
Analysis and Services Office, CDC, pursuant to Public Law 92-463. The 
grant applications and the discussions could disclose confidential 
trade secrets or commercial property such as patentable material, and 
personal information concerning individuals associated with the grant 
applications, the disclosure of which would constitute a clearly 
unwarranted invasion of personal privacy.

    Name of Committee: Disease, Disability, and Injury Prevention 
and Control Special Emphasis Panel; (SEP) DP18-001, Etiology and 
Outcome of Inflammatory Bowel Disease.
    Date: April 11, 2018.
    Time: 11:00 a.m.-6:00 p.m., EDT.
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention 
and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2018-02829 Filed 2-12-18; 8:45 am]
 BILLING CODE 4163-18-P

Federal Register / Vol. 83, No. 30 / Tuesday, February 13, 2018 / Notices 6177

the Director, Management Analysis and Exposure and Prevention Advisory the discussions could disclose
Services Office, CDC, pursuant to Public Committee shall, at a minimum: (1) confidential trade secrets or commercial
Law 92–463. The grant applications and Review the Federal programs and property such as patentable material,
the discussions could disclose services available to individuals and and personal information concerning
confidential trade secrets or commercial communities exposed to lead; (2) review individuals associated with the grant
property such as patentable material, current research on lead exposure to applications, the disclosure of which
and personal information concerning identify additional research needs; (3) would constitute a clearly unwarranted
individuals associated with the grant review and identify best practices, or invasion of personal privacy.
applications, the disclosure of which the need for best practices regarding Name of Committee: Disease, Disability,
would constitute a clearly unwarranted lead screening and the prevention of and Injury Prevention and Control Special
invasion of personal privacy. lead poisoning; (4) identify effective Emphasis Panel; (SEP) DP18–001, Etiology
Name of Committee: Disease, Disability, services, including services relating to and Outcome of Inflammatory Bowel Disease.
and Injury Prevention and Control Special healthcare, education, and nutrition for Date: April 11, 2018.
Emphasis Panel (SEP); Funding Opportunity individuals and communities affected Time: 11:00 a.m.–6:00 p.m., EDT.
Announcement (FOA), IP18–001, Reducing by lead exposure and lead poisoning, Place: Teleconference.
Disparities in Vaccination Coverage by including in consultation with, as Agenda: To review and evaluate grant
Poverty Status Among Young Children and applications.
appropriate, the lead exposure registry For Further Information Contact: Jaya
IP18–003, Understanding and Addressing the as established in Section 2203(b) of
Disparity in Vaccination Coverage Among Raman Ph.D., Scientific Review Officer, CDC,
Public Law 114–322; and (5) undertake 4770 Buford Highway, Mailstop F80, Atlanta,
U.S. Adolescents Living in Rural versus
Urban Areas. any other review or activities that the Georgia 30341, Telephone: (770) 488–6511,
Dates: March 20, 2018 and March 21, 2018. Secretary determines to be appropriate. kva5@cdc.gov.
Time: 10:00 a.m.–5:00 p.m. (EDT) This advisory committee will review The Director, Management Analysis and
Place: Teleconference, Centers for Disease research and Federal programs and Services Office, has been delegated the
Control and Prevention, Room 1080, 8 services related to lead poisoning and to authority to sign Federal Register notices
Corporate, Atlanta, GA 30329. pertaining to announcements of meetings and
identify effective services and best
Agenda: To review and evaluate grant other committee management activities, for
practices for addressing and preventing both the Centers for Disease Control and
applications.
For Further Information Contact: Gregory
lead exposures in communities. Prevention and the Agency for Toxic
Anderson, M.S., M.P.H., Scientific Review FOR FURTHER INFORMATION CONTACT: Substances and Disease Registry.
Officer, CDC, 1600 Clifton Road NE, Mailstop Perri Ruckart, M.P.H., Epidemiologist,
Elaine L. Baker,
E–60, Atlanta, Georgia 30333, (404) 718– CDC, 4770 Buford Highway NE, Atlanta,
8833, gca5@cdc.gov. Director, Management Analysis and Services
Georgia 30341, telephone (770) 488–
The Director, Management Analysis and Office, Centers for Disease Control and
3808; afp4@cdc.gov. Prevention.
Services Office, has been delegated the The Director, Management Analysis
authority to sign Federal Register Notices [FR Doc. 2018–02829 Filed 2–12–18; 8:45 am]
and Services Office, has been delegated
pertaining to announcements of meetings and BILLING CODE 4163–18–P
other committee management activities, for the authority to sign Federal Register
both the Centers for Disease Control and notices pertaining to announcements of
Prevention and the Agency for Toxic meetings and other committee
DEPARTMENT OF HEALTH AND
Substances and Disease Registry. management activities, for both the
HUMAN SERVICES
Centers for Disease Control and
Elaine L. Baker,
Prevention and the Agency for Toxic Centers for Disease Control and
Director, Management Analysis and Services
Substances and Disease Registry. Prevention
Office, Centers for Disease Control and
Prevention. Elaine L. Baker,
Notice of Closed Meeting
[FR Doc. 2018–02826 Filed 2–12–18; 8:45 am] Director, Management Analysis and Services
BILLING CODE 4163–18–P Office, Centers for Disease Control and Pursuant to section 10(d) of the
Prevention. Federal Advisory Committee Act, as
[FR Doc. 2018–02823 Filed 2–12–18; 8:45 am] amended, notice is hereby given of the
DEPARTMENT OF HEALTH AND BILLING CODE 4163–18–P following meeting.
HUMAN SERVICES The meeting will be closed to the
public in accordance with the
Centers for Disease Control and DEPARTMENT OF HEALTH AND provisions set forth in sections
Prevention HUMAN SERVICES 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
Lead Exposure and Prevention Centers for Disease Control and the Director, Management Analysis and
Advisory Committee (LEPAC); Notice Prevention Services Office, CDC, pursuant to Public
of Establishment
Notice of Closed Meeting Law 92–463. The grant applications and
ACTION: Notice of charter establishment. the discussions could disclose
Pursuant to section 10(d) of the confidential trade secrets or commercial
SUMMARY: Pursuant to the Section 2203 Federal Advisory Committee Act, as property such as patentable material,
of Public Law 114–322 (Water amended, notice is hereby given of the and personal information concerning
Infrastructure Improvements for the following meeting. individuals associated with the grant
Nation Act)(Registry for Lead Exposure The meeting will be closed to the
sradovich on DSK3GMQ082PROD with NOTICES

applications, the disclosure of which
and Advisory Committee), and the public in accordance with the would constitute a clearly unwarranted
Federal Advisory Committee Act of provisions set forth in sections invasion of personal privacy.
October 6, 1972, the Director, Centers 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Name of Committee: Disease, Disability,
for Disease Control and Prevention as amended, and the Determination of and Injury Prevention and Control Special
(CDC), announces the establishment of the Director, Management Analysis and Emphasis Panel (SEP); DD18–001, Birth
the Lead Exposure and Prevention Services Office, CDC, pursuant to Public Defects Study To Evaluate Pregnancy
Advisory Committee. The Lead Law 92–463. The grant applications and exposureS (BD–STEPS) II.

VerDate Sep<11>2014 23:12 Feb 12, 2018 Jkt 244001 PO 00000 Frm 00019 Fmt 4703 Sfmt 4703 E:\FR\FM\13FEN1.SGM 13FEN1

Document Created: 2018-02-13 02:32:14
Document Modified: 2018-02-13 02:32:14

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		April 11, 2018.
Contact		Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488-6511, [email protected]
FR Citation		83 FR 6177

83 FR 6177 - Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 83, Issue 30 (February 13, 2018)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention